Spotlight Innovation — Investor Presentation (July 2014)
10 slides from Spotlight Innovation's investor presentation, Jul 29, 2014
Slide 1: Corporate Presentation July 2014
4 SPOTLIG INNOVATION SOLUTIONS\FOR HIGH IMPACT HEALTHCARE CORPORATE PRESE ION JULY 2014 = a
Slide 2: Spotlight Innovation, Inc.
SPOTLIGHT INNOVATION Spotlight Innovation, Inc. 2014 TODAY Trading as Value Creation Engine STLT Healthcare Technology 2013 Merger Completed . Healthcare track record/expertise Evergreen funding model Institutional commitment OTCQB:STLT www.Spotlightinnovation.com ‘Ask to see our disclosures regardi
Slide 3: Goals
Goals * Expansion of University partner base * Develop value drivers * Identify potential IP technology and company acquisitions * Develop Intellectual Property DEVELOP BUILD IP ro) VALUE REALIZE VALUE www SpotlightInnovation.com ‘Ask to see our disclosures regarding ‘Risk Factors’ 3
Slide 4: Overview
Overview INDUSTRY SUBSIDIARY HEALTHCARE * Celtic Biotech lowa, Inc. — Pharmaceuticals — Drug Manufacturing eo CELTICBIOTECH — Biotechnology DEVELOPMENT PHASE ¢ Pre-Revenue Development * Initial Revenue * Expansion www. Spotlight innovation.com ‘Asko see our disdosures regarding ‘Risk Factor q.
Slide 5: Celtic Biotech: Anti-cancer therapy (CB24)
e SPOTLIGHT @{CELTICBIOTECH — Anti-cancer therapy (CB24) — Non-toxic, non-side effect inducing monotherapy — Broad activity against a variety of tumor cell types — Relatively simple to produce and is stable — Studies indicate significant analgesic effects * Phase 1 human safety studies complete * Ma
Slide 6: Milestones Achieved
SPOTLIGHT 4) INNOVATION Milestones Achieved * DEC 2013: AEXP/Spotlight Innovation merger completed * MARCH 2014: Celtic Biotech lowa, Inc., becomes wholly-owned subsidiary of Spotlight Innovation, Inc. * APRIL 2014: Spotlight Innovation received $752,325 Line of Credit from Denver Savings Bank, secu
Slide 7: Why Spotlight Innovation?
SPOTLIGHT INNOVATION Why Spotlight Innovation? Limited Regional Competition Proven team Readily available University-developed healthcare intellectual property Letter of Credit completed: $750K (April 2014) Additional Letter of Credit: $250K (July 29, 2014) Completed equity placement of more than $4
Slide 8: Thank You
Thank You SPOTLIGHT INNOVATION www.SpotlightInnovation.com ‘Ask to see ourdisclosures regarding ‘Risk Factors’ g
Slide 9: Connect with Us
SPOTLIGHT INNOVATION Connect with Us Cristopher Grunewald President and CEO Cell: 515-669-1215 Address: 6750 Westown Pkwy Suite 200-226 West Des Moines IA 50266 Phone: 515-274-9087 Email: Cristopher.Grunewald@SpotlightInnovation.com in | vwwlinkedin.com/company/spotlight-innovation FE oot conysersso
Slide 10: Forward Looking Statements
SPOTLIGHT 4) INNOVATION Forward Looking Statements Certain statements in this presentation may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by th
Spotlight Innovation — Investor Presentation (July 2014) on 6ix